Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
At a glance
Conditions
NCT06823115
Where you'd take part
This study runs at 87 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Aghia Sofia Children's Hospital
Athens, Greeceno site contact published
Akron Children's Hospital
Akron, Ohiono site contact published
Alberta Children's Hospital/University of Calgary
Calgary, Canadano site contact published
Amalia Children's Hospital Radboudumc
Nijmegen, Netherlandsno site contact published
Ankara Bilkent City Hospital, Children Hospital
Ankara, Turkey (Türkiye)no site contact published
Aristotle University
Thessaloniki, Greeceno site contact published
Baptist Health South Florida/South Miami Hospital
South Miami, Floridano site contact published
Boston Children's Hospital
Boston, Massachusettsno site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Neonatal Acute Kidney InjuryUp to 6 months or NICU discharge, whichever comes first
The investigators will evaluate the rate of neonatal AKI among infants that meet inclusion criteria across all sites. Neonatal Acute Kidney Injury will be defined by the standard neonatal definitions, including serum creatinine values and urine output (when available). Furthermore, investigators will examine if different thresholds or definitions of AKI will better predict outcomes.